Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
$85.68
-1.3%
$88.19
$80.39
$122.53
$7.16B1.02819,196 shs143,168 shs
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$204.06
-0.7%
$197.09
$137.99
$211.78
$14.35B0.86403,948 shs65,054 shs
McDonald's Corporation stock logo
MCD
McDonald's
$303.03
-0.4%
$306.27
$276.53
$326.32
$216.24B0.53.53 million shs661,397 shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$78.40
-1.6%
$82.63
$73.31
$114.79
$195.84B0.3714.95 million shs3.01 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$23.79
-1.3%
$24.59
$20.92
$30.43
$135.23B0.5545.16 million shs18.67 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
-0.49%-0.55%-1.70%-7.76%-6.59%
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
-1.53%+0.91%+4.82%+12.61%+27.17%
McDonald's Corporation stock logo
MCD
McDonald's
+0.40%-0.06%-2.82%+6.49%+1.36%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-0.33%-1.84%-6.80%+0.87%-30.74%
Pfizer Inc. stock logo
PFE
Pfizer
-0.23%+0.15%-4.31%-0.98%-18.47%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
$85.68
-1.3%
$88.19
$80.39
$122.53
$7.16B1.02819,196 shs143,168 shs
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$204.06
-0.7%
$197.09
$137.99
$211.78
$14.35B0.86403,948 shs65,054 shs
McDonald's Corporation stock logo
MCD
McDonald's
$303.03
-0.4%
$306.27
$276.53
$326.32
$216.24B0.53.53 million shs661,397 shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$78.40
-1.6%
$82.63
$73.31
$114.79
$195.84B0.3714.95 million shs3.01 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$23.79
-1.3%
$24.59
$20.92
$30.43
$135.23B0.5545.16 million shs18.67 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
-0.49%-0.55%-1.70%-7.76%-6.59%
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
-1.53%+0.91%+4.82%+12.61%+27.17%
McDonald's Corporation stock logo
MCD
McDonald's
+0.40%-0.06%-2.82%+6.49%+1.36%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-0.33%-1.84%-6.80%+0.87%-30.74%
Pfizer Inc. stock logo
PFE
Pfizer
-0.23%+0.15%-4.31%-0.98%-18.47%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
2.00
Hold$98.3814.82% Upside
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
2.60
Moderate Buy$210.603.20% Upside
McDonald's Corporation stock logo
MCD
McDonald's
2.33
Hold$325.867.53% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.33
Hold$106.4135.72% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.39
Hold$28.1218.22% Upside

Current Analyst Ratings Breakdown

Latest MCD, HLI, PFE, MRK, and ALSN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/19/2025
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
9/17/2025
McDonald's Corporation stock logo
MCD
McDonald's
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$373.00 ➝ $381.00
9/17/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyHold$100.00 ➝ $90.00
9/8/2025
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$192.00 ➝ $213.00
9/4/2025
McDonald's Corporation stock logo
MCD
McDonald's
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$350.00 ➝ $360.00
8/22/2025
McDonald's Corporation stock logo
MCD
McDonald's
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$300.00 ➝ $315.00
8/19/2025
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHoldStrong Sell
8/8/2025
McDonald's Corporation stock logo
MCD
McDonald's
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
8/8/2025
McDonald's Corporation stock logo
MCD
McDonald's
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$350.00 ➝ $360.00
8/7/2025
McDonald's Corporation stock logo
MCD
McDonald's
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$325.00 ➝ $335.00
8/7/2025
McDonald's Corporation stock logo
MCD
McDonald's
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$305.00 ➝ $310.00
(Data available from 9/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
$3.20B2.24$9.80 per share8.74$19.31 per share4.44
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$2.48B5.78$6.64 per share30.71$31.14 per share6.55
McDonald's Corporation stock logo
MCD
McDonald's
$26.06B8.30$14.72 per share20.58($5.30) per share-57.18
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$63.62B3.08$9.28 per share8.45$18.33 per share4.28
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.13$4.30 per share5.53$15.62 per share1.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
$731M$8.809.748.52N/A23.81%45.56%14.19%11/4/2025 (Estimated)
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$399.71M$5.9434.3528.15N/A16.46%23.75%14.21%10/29/2025 (Estimated)
McDonald's Corporation stock logo
MCD
McDonald's
$8.22B$11.6725.9722.853.0932.21%-225.52%15.07%11/4/2025 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$17.12B$6.4912.087.920.8225.79%41.05%16.55%10/30/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.8812.657.850.8516.84%21.42%9.12%11/4/2025 (Estimated)

Latest MCD, HLI, PFE, MRK, and ALSN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
McDonald's Corporation stock logo
MCD
McDonald's
$3.15$3.19+$0.04$3.14$6.68 billion$6.84 billion
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.58$0.78+$0.20$0.51$13.43 billion$14.65 billion
8/4/2025Q2 2025
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
$2.20$2.29+$0.09$2.29$811.05 million$814.00 million
7/29/2025Q1 2026
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$1.69$2.14+$0.45$1.42$573.07 million$605.35 million
7/29/2025Q2 2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.03$2.13+$0.10$1.76$15.92 billion$15.81 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
$1.081.26%N/A12.27%2 Years
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$2.401.18%N/A40.40%9 Years
McDonald's Corporation stock logo
MCD
McDonald's
$7.082.34%N/A60.67%49 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.244.13%N/A49.92%14 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.23%N/A91.49%16 Years

Latest MCD, HLI, PFE, MRK, and ALSN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/22/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.814%9/15/20259/15/202510/7/2025
7/22/2025
McDonald's Corporation stock logo
MCD
McDonald's
quarterly$1.772.24%9/2/20259/2/20259/16/2025
7/30/2025
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
quarterly$0.601.22%9/2/20259/2/20259/15/2025
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
8/8/2025
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
quarterly$0.271.2%8/20/20258/20/20258/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
1.37
3.36
2.64
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
N/A
1.37
1.37
McDonald's Corporation stock logo
MCD
McDonald's
N/A
1.30
1.29
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.69
1.42
1.17
Pfizer Inc. stock logo
PFE
Pfizer
0.65
1.16
0.85

Institutional Ownership

CompanyInstitutional Ownership
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
96.90%
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
78.07%
McDonald's Corporation stock logo
MCD
McDonald's
70.29%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
1.10%
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
22.83%
McDonald's Corporation stock logo
MCD
McDonald's
0.25%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.13%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allison Transmission Holdings, Inc. stock logo
ALSN
Allison Transmission
4,00083.62 million82.70 millionOptionable
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
1,10070.31 million54.26 millionOptionable
McDonald's Corporation stock logo
MCD
McDonald's
150,000713.60 million711.82 millionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.50 billion2.49 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable

Recent News About These Companies

Pfizer Inc. $PFE Shares Purchased by Penn Davis Mcfarland Inc.
Pfizer Tries To Fatten Its Profits With Weight Loss Drugs
Santori & Peters Inc. Purchases 11,000 Shares of Pfizer Inc. $PFE
Pfizer Finalizes Licensing Deal With 3SBio

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allison Transmission stock logo

Allison Transmission NYSE:ALSN

$85.68 -1.14 (-1.31%)
As of 11:20 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Allison Transmission Holdings, Inc., together with its subsidiaries, designs, manufactures, and sells fully automatic transmissions for medium- and heavy-duty commercial vehicles and medium- and heavy-tactical U.S. defense vehicles, and electrified propulsion systems worldwide. It provides commercial-duty on-highway, off-highway and defense fully automatic transmissions, and electric hybrid and fully electric systems. The company offers transmissions for various applications, including distribution, refuse, construction, fire, and emergency on-highway trucks; school and transit buses; motor homes; energy, mining, and construction off-highway vehicles and equipment; and wheeled and tracked defense vehicles. It provides its transmissions and electric propulsion solutions under the Allison Transmission brand name; and remanufactured transmissions under the ReTran brand name. The company also sells branded replacement parts, support equipment, aluminum die cast components, and other products necessary to service the installed base of vehicles utilizing its solutions, as well as defense kits, engineering services, and extended transmission coverage services to various original equipment manufacturers, distributors, and the U.S. government. It serves customers through an independent network of approximately 1,600 independent distributor and dealer locations. The company was formerly known as Clutch Holdings, Inc. Allison Transmission Holdings, Inc. was founded in 1915 and is headquartered in Indianapolis, Indiana.

Houlihan Lokey stock logo

Houlihan Lokey NYSE:HLI

$204.06 -1.52 (-0.74%)
As of 11:20 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, solvency opinions in connection with corporate spin-offs and dividend recapitalizations, and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, financial sponsors, and government agencies. The company was incorporated in 1972 and is headquartered in Los Angeles, California.

McDonald's stock logo

McDonald's NYSE:MCD

$303.03 -1.30 (-0.43%)
As of 11:21 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$78.40 -1.27 (-1.59%)
As of 11:21 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Pfizer stock logo

Pfizer NYSE:PFE

$23.78 -0.31 (-1.27%)
As of 11:21 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.